drugset / Trial / NCT00786318

Ziprasidone vs Standard Therapy for Agitated Patients in the ED

NCT00786318

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to determine if ziprasidone is superior to standard therapies in the emergency department treatment of the acutely agitated patient. The primary outcome will be the length of time taken until the patient is ready to be evaluated by the psychiatric service, or until a disposition is made.

Timeline

Start
2008-09
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified 5 mg Intramuscular
Comparator Lorazepam Small molecule 2 mg Intramuscular
Subject Ziprasidone Small molecule 20 mg Intramuscular